西藏地区系统性红斑狼疮患者的临床特征OA
Comparison of clinical features of systemic lupus erythematosus between Tibetan and non-Tibetan populations
目的 系统分析西藏地区藏族系统性红斑狼疮(SLE)患者的临床特征,并与同期内地中心就诊的非藏族 SLE 患者进行对比,探讨高原环境与人群背景对疾病表型的影响.方法 本研究采用临床队列研究设计,连续性纳入 1999 年至 2025 年在西藏自治区人民医院及北京协和医院确诊的SLE 患者,按民族分为藏族组与非藏族组.系统收集并比较两组患者的人口学特征、临床表现、血清学指标、治疗方案及预后情况.结果 共纳入 1 840 例患者进行分析,其中藏族组 268 例,非藏族组1 572 例.藏族组患者发病年龄更大(34 岁 vs 26 岁,P<0.001),病程更短(5 个月 vs 60 个月,P<0.001).单因素分析显示藏族组皮肤黏膜、关节炎、浆膜炎及间质性肺病发生率更高;多因素回归分析校正年龄及病程后,藏族民族仍独立关联于上述表型(皮肤黏膜 aOR=2.074,关节炎 aOR=2.152,浆膜炎 aOR=1.449,间质性肺病 aOR=18.848,均P<0.05).血清学方面,藏族组抗干燥综合征 A(SSA)抗体、抗干燥综合征 B(SSB)抗体阳性率更高(P<0.05).治疗上,藏族组激素与环磷酰胺使用率更高(P<0.05).非藏族组狼疮肾炎累积完全缓解率(CR)高于藏族组(P<0.05).结论 藏族组 SLE 患者具有独特的临床表型,以皮肤、关节和肺部受累为主.
Objective To systematically describe and compare the clinical features of systemic lupus er-ythematosus(SLE)patients between a high-altitude center in Tibet and a low-altitude center,thereby explo-ring the influence of high-altitude environment and population background on disease manifestations.Methods This clinical cohort study consecutively enrolled patients diagnosed with SLE between 1999 and 2025 at the Peo-ple's Hospital of the Tibet Autonomous Region and Peking Union Medical College Hospital.Patients were cate-gorized into Tibetan and non-Tibetan groups according to ethnicity.Demographic characteristics,clinical mani-festations,serological findings,treatment regimens,and outcomes were systematically collected and compared between the two groups.Results A total of 1 840 patients were included in the analysis,comprising 268 Ti-betan patients and 1 572 non-Tibetan patients.Tibetan patients had an older age at disease onset(34 vs 26 years,P<0.001)and a shorter disease duration(5 vs 60 months,P<0.001).Univariate analysis showed that the Tibetan group had higher incidences of mucocutaneous involvement,arthritis,serositis,and intersti-tial lung disease.After adjusting for age and disease duration,multivariate regression analysis revealed that Ti-betan ethnicity remained independently associated with these phenotypes(mucocutaneous involvement:aOR=2.074;arthritis:aOR=2.152;serositis:aOR=1.449;interstitial lung disease:aOR=18.848;all P<0.05).The prevalence of mucocutaneous involvement,arthritis,serositis,and interstitial lung disease was significantly higher in the Tibetan group(all P<0.05).Serologically,Tibetan patients had higher positivity rates for anti-Sjögren's syndrome A(SSA)and anti-Sjögren's syndrome B(SSB)antibodies(both P<0.05).In terms of treatment,glucocorticoids and cyclophosphamide were more frequently used in the Tibetan group(P<0.05).Conversely,the cumulative complete remission(CR)rate of lupus nephritis was higher in the non-Tibetan group(P<0.05).Conclusions Tibetan SLE patients exhibit a distinct clinical phenotype,pre-dominantly characterized by mucocutaneous,joint,and pulmonary involvement.
拉曲;陈思运;罗增;格桑曲珍;平措卓嘎;黄璨;白玛央金;赵久良;李梦涛
850000 拉萨,西藏自治区人民医院风湿免疫血液科100730 北京,中国医学科学院 北京协和医学院 北京协和医院风湿免疫科850000 拉萨,西藏自治区人民医院风湿免疫血液科850000 拉萨,西藏自治区人民医院风湿免疫血液科850000 拉萨,西藏自治区人民医院风湿免疫血液科100730 北京,中国医学科学院 北京协和医学院 北京协和医院风湿免疫科850000 拉萨,西藏自治区人民医院风湿免疫血液科100730 北京,中国医学科学院 北京协和医学院 北京协和医院风湿免疫科100730 北京,中国医学科学院 北京协和医学院 北京协和医院风湿免疫科
系统性红斑狼疮藏族临床特点血清学预后
systemic lupus erythematosusTibetanclinical featuresserologyprognosis
《中华临床免疫和变态反应杂志》 2026 (4)
249-256,8
西藏自治区自然科学基金组团式医学援藏项目(XZ2024ZR-ZY024(Z))北京协和医院中央高水平医院临床科研专项项目(2025-PUMCH-A-032)
评论